FDA Alerts on Shortage of Breast Biopsy Needles

Needles used to detect breast cancer in shortage from recall

The Food and Drug Administration said that the US is experiencing a shortage of breast biopsy needles after Hologic Inc. recalled the products earlier this year, potentially causing delays in diagnosing the most common cancer in women. The shortage is expected to last through March 2027, the FDA said in a statement. It advised doctors to take measures to conserve their supply of needles.  Hologic started a recall in January following reports of …

FDA warns breast biopsy needle shortage to continue into 2027

The shortage follows Hologic removing certain breast biopsy needles from the market in January.

FDA Alerts on Shortage of Breast Biopsy Needles

(MedPage Today) -- The FDA informed healthcare providers about disruptions in the supply of stereotactic breast biopsy needles that will likely persist through March 2027. According to the agency, the disruption is expected to impact patient care...

FDA says shortage of breast biopsy needles expected to last until 2027

The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of March 2027. The FDA said the shortage is due to a manufacturing disruption and that clinical management adjustments may be required for patients needing a breast biopsy. Healthcare providers are recommended to conserve their use of stereotactic breast biopsy needles. The agency said that Holog…

FDA shares update on breast biopsy needle shortage

The supply shortfall pertains to Brevera Breast Biopsy System Disposable 9 Gauge Needles manufactured by Hologic.